ANTITUMOR 2-AMINOCARBONYL-1,2-BIS(METHYLSULFONYL)-1-(SUBSTITUTED)HYDRAZINES
    1.
    发明公开
    ANTITUMOR 2-AMINOCARBONYL-1,2-BIS(METHYLSULFONYL)-1-(SUBSTITUTED)HYDRAZINES 失效
    抗肿瘤2-氨基羰基-1,2-双(甲基磺酰基)-1-(取代的)肼

    公开(公告)号:EP0841912A1

    公开(公告)日:1998-05-20

    申请号:EP96923609.0

    申请日:1996-07-02

    申请人: YALE UNIVERSITY

    IPC分类号: A61K31 A61P35 C07C311 C07C317

    CPC分类号: C07C311/55

    摘要: The present invention relates to novel 2-aminocarbonyl-1,2-bis(methylsulfonyl)-1-(2-chloroethyl)hydrazines and 2-aminocarbonyl-1,2-bis(methylsulfonyl)-1-methylhydrazines, and their use to treat malignant tumors. The agents are especially useful in the treatment of animal and human cancers. Two preferred agents in this class, especially for use in the treatment of tumors are 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)-2-(2-chloroethyl)aminocarbonylhydrazine and 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)-2-methylaminocarbonylhydrazine. These agents are characterized by the following: they are incapable of undergoing inactivation by the denitrosation mechanism proposed for the inactivation of the CNUs roethylation or methylation and carbamoylation.